Annual report pursuant to Section 13 and 15(d)

Impact to Reported Results of the Adoption of ASC 606, Revenue from Contracts with Customers - Consolidated Statements of Operations (Details)

v3.8.0.1
Impact to Reported Results of the Adoption of ASC 606, Revenue from Contracts with Customers - Consolidated Statements of Operations (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 12 Months Ended
Dec. 30, 2017
Sep. 30, 2017
Jul. 01, 2017
Apr. 01, 2017
Dec. 31, 2016
Sep. 24, 2016
Jun. 25, 2016
Mar. 26, 2016
Dec. 30, 2017
Dec. 31, 2016
Dec. 26, 2015
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Net revenue $ 1,480 $ 1,643 $ 1,222 $ 984 $ 1,106 $ 1,307 $ 1,027 $ 832 $ 5,329 $ 4,272 $ 3,991
Cost of sales 965 1,070 818 653 755 1,248 708 563 3,506 3,274 2,911
Gross margin 515 573 404 331 351 59 319 269 1,823 998 1,080
Research and development 300 315 279 266 264 259 243 242 1,160 1,008 947
Marketing, general and administrative 133 132 125 121 121 117 117 105 511 460 482
Restructuring and other special charges, net 0 0 0 0 0 0 (7) (3) 0 (10) 129
Licensing gain 0 0 (25) (27) (31) (24) (26) (7) (52) (88) 0
Operating income (loss) 82 126 25 (29) (3) (293) (8) (68) 204 (372) (481)
Interest expense (31) (31) (32) (32) (34) (41) (41) (40) (126) (156) (160)
Other income (expense), net 2 (3) (3) (5) (7) (63) 150 0 (9) 80 (5)
Income (loss) before equity loss and income taxes                 69 (448) (646)
Provision for income taxes (8) 19 3 5 5 4 29 1 19 39 14
Equity loss in investee 0 (2) (3) (2) (2) (5) (3) 0 (7) (10) 0
Net income (loss) $ 61 $ 71 $ (16) $ (73) $ (51) $ (406) $ 69 $ (109) $ 43 $ (497) $ (660)
Earnings (loss) per share                      
Basic (USD per share) $ 0.06 $ 0.07 $ (0.02) $ (0.08) $ (0.06) $ (0.50) $ 0.09 $ (0.14) $ 0.04 $ (0.60) $ (0.84)
Diluted (USD per share) $ 0.06 $ 0.07 $ (0.02) $ (0.08) $ (0.06) $ (0.50) $ 0.08 $ (0.14) $ 0.04 $ (0.60) $ (0.84)
Shares used in per share calculation                      
Basic (shares) 965 957 945 939 931 815 794 793 952 835 783
Diluted (shares) 1,037 1,042 945 939 931 815 821 793 1,039 835 783
Pro Forma | Accounting Standards Update 2014-09                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Net revenue                 $ 5,253 $ 4,319  
Cost of sales                 3,466 3,316  
Gross margin                 1,787 1,003  
Research and development                 1,196 1,008  
Marketing, general and administrative                 516 466  
Restructuring and other special charges, net                 0 (10)  
Licensing gain                 (52) (88)  
Operating income (loss)                 127 (373)  
Interest expense                 (126) (156)  
Other income (expense), net                 (9) 80  
Income (loss) before equity loss and income taxes                 (8) (449)  
Provision for income taxes                 18 39  
Equity loss in investee                 (7) (10)  
Net income (loss)                 $ (33) $ (498)  
Earnings (loss) per share                      
Basic (USD per share)                 $ (0.03) $ (0.60)  
Diluted (USD per share)                 $ (0.03) $ (0.60)  
Shares used in per share calculation                      
Basic (shares)                 952 835  
Diluted (shares)                 952 835  
Pro Forma | Difference between Revenue Guidance in Effect before and after Topic 606 | Accounting Standards Update 2014-09                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Net revenue                 $ (76) $ 47  
Cost of sales                 (40) 42  
Gross margin                 (36) 5  
Research and development                 36 0  
Marketing, general and administrative                 5 6  
Restructuring and other special charges, net                 0 0  
Licensing gain                 0 0  
Operating income (loss)                 (77) (1)  
Interest expense                 0 0  
Other income (expense), net                 0 0  
Income (loss) before equity loss and income taxes                 (77) (1)  
Provision for income taxes                 (1) 0  
Equity loss in investee                 0 0  
Net income (loss)                 $ (76) $ (1)  
Earnings (loss) per share                      
Basic (USD per share)                 $ (0.07) $ 0.00  
Diluted (USD per share)                 $ (0.07) $ 0.00  
Pro Forma | Calculated under Revenue Guidance in Effect before Topic 606 | Accounting Standards Update 2014-09                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Net revenue                 $ 5,329 $ 4,272  
Cost of sales                 3,506 3,274  
Gross margin                 1,823 998  
Research and development                 1,160 1,008  
Marketing, general and administrative                 511 460  
Restructuring and other special charges, net                 0 (10)  
Licensing gain                 (52) (88)  
Operating income (loss)                 204 (372)  
Interest expense                 (126) (156)  
Other income (expense), net                 (9) 80  
Income (loss) before equity loss and income taxes                 69 (448)  
Provision for income taxes                 19 39  
Equity loss in investee                 (7) (10)  
Net income (loss)                 $ 43 $ (497)  
Earnings (loss) per share                      
Basic (USD per share)                 $ 0.04 $ (0.60)  
Diluted (USD per share)                 $ 0.04 $ (0.60)  
Shares used in per share calculation                      
Basic (shares)                 952 835  
Diluted (shares)                 1,039 835